{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "LIFE",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 9210000
            },
            {
                "label": "Available-for-sale investments, short-term",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 21934000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 781000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 31925000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1270000
            },
            {
                "label": "Right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 2821000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 172000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 36188000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 847000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2376000
            },
            {
                "label": "Contract liability",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 208000
            },
            {
                "label": "Current portion of operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 755000
            },
            {
                "label": "Current portion of long-term debt, net of issuance costs and discount",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 8737000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 12923000
            },
            {
                "label": "Long-term operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 2239000
            },
            {
                "label": "Commitments and contingencies (Note 6)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value per share; 5,000,000 undesignated authorized shares; Class X Convertible Preferred Stock issued and outstanding shares \u2013 1,643,961 and 2,285,952 as of December 31, 2019 and 2018, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Common stock, $0.001 par value per share; 10,714,286 authorized shares; issued and outstanding shares \u2013 3,891,787 and 2,186,389 as of December 31, 2019 and 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 343524000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -40000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -322304000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 21186000
            },
            {
                "label": "Noncontrolling interest in Pangu BioPharma Limited",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -160000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 21026000
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 36188000
            }
        ],
        "cf": [
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -23763000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 635000
            },
            {
                "label": "Stock-based compensation",
                "concept": "AllocatedShareBasedCompensationExpense",
                "unit": "usd",
                "value": 1783000
            },
            {
                "label": "Debt discount accretion and non-cash interest expense",
                "concept": "AccretionExpense",
                "unit": "usd",
                "value": 707000
            },
            {
                "label": "Amortization (accretion) of premium (discount) of available-for-sale investment securities",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 284000
            },
            {
                "label": "Operating lease right of use asset amortization.",
                "concept": "life:OperatingLeaseRightOfUseAssetAmortization",
                "unit": "usd",
                "value": 731000
            },
            {
                "label": "(Gain) loss on disposal of property and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": 28000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -334000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 162000
            },
            {
                "label": "Contract liability",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 208000
            },
            {
                "label": "Increase (decrease) in operating lease liability.",
                "concept": "life:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -498000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -20013000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 79000
            },
            {
                "label": "Purchases of available-for-sale investment securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 40647000
            },
            {
                "label": "Maturities of available-for-sale investment securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 45600000
            },
            {
                "label": "Proceeds from sale of property and equipment",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 51000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 4925000
            },
            {
                "label": "Proceeds from issuance of common stock under employee stock purchase plan.",
                "concept": "life:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Proceeds from issuance of common stock through at market offering net of offering costs.",
                "concept": "life:ProceedsFromIssuanceOfCommonStockThroughAtMarketOfferingNetOfOfferingCosts",
                "unit": "usd",
                "value": 4405000
            },
            {
                "label": "Proceeds from issuance of common stock through registered direct offering, net of offering costs.",
                "concept": "life:ProceedsFromIssuanceOfCommonStockThroughRegisteredDirectOfferingNetOfOfferingCosts",
                "unit": "usd",
                "value": 4918000
            },
            {
                "label": "Repayments on borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": 8000000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 1336000
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -13752000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 1122000
            }
        ],
        "ic": [
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 422000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 14048000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9352000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 23400000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -22978000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -785000
            },
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -23763000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Pangu BioPharma Limited",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -160000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Pangu BioPharma Limited",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -23603000
            },
            {
                "label": "Net loss per share attributable to common stockholders, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -7.03
            },
            {
                "label": "Weighted average common stock shares outstanding, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 3355600
            },
            {
                "label": "Change in unrealized gain (loss) on available-for-sale investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 20000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -23743000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interest Pangu BioPharma Limited",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -160000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -23583000
            }
        ]
    }
}